Sclerosis News and Research

RSS

Patients with MS more likely to develop MI and stroke, regardless of migration background

A new study from Karolinska Institutet in Sweden shows that patients with multiple sclerosis (MS) run a high risk of heart attack, stroke and heart failure, regardless of migration background. According to Dr Tahereh Moradi, principal investigator, the study is the first in the world to examine the risk of cardiovascular diseases in male and female MS patients with both non-immigrant and immigrant backgrounds.

5 Feb 2013

NSU-COM to hold grand opening for America's first Institute for Neuro Immune Medicine

Nova Southeastern University's College of Osteopathic Medicine (NSU-COM) will hold a grand opening for America's first Institute for Neuro Immune Medicine on Feb. 12.

5 Feb 2013

USPTO issues patent to KAHR-101 for treatment of cancers, arthritis and MS

Hadasit Bio-Holdings Ltd., a publicly traded portfolio of biotech companies, based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced that its portfolio company, KAHR Medical Ltd., was granted a U.S. patent approval (U.S. Patent No. 8329657).

5 Feb 2013

Adequate vitamin D levels during young adulthood may reduce risk of type 1 diabetes

Having adequate levels of vitamin D during young adulthood may reduce the risk of adult-onset type 1 diabetes by as much as 50%, according to researchers at Harvard School of Public Health (HSPH).

5 Feb 2013

Eating brightly colored fruit and veg may help prevent ALS

Having a high intake of carotenoids, compounds that give certain fruits and vegetables their distinctive coloring, can reduce a person’s risk for developing amyotrophic lateral sclerosis or motor neurone disease, suggest study findings.

4 Feb 2013

Three Robert Wood Johnson members win Edward J. Ill Excellence in Medicine Awards

Three members of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School faculty have been named 2013 recipients of the prestigious Edward J. Ill Excellence in Medicine Awards, highlighting their expertise as exceptional educators or researchers.

1 Feb 2013

Supplementation with omega-3 fatty acids promotes effective immune system response

Supplementation with omega-3 fatty acids promotes effective immune system response and has ameliorating effects on chronic inflammation (a condition caused by an imbalanced immune system that can lead to multiple serious illnesses over time), according to the most recent study published by the National Center for Biotechnology Information on the effects of omega-3.

31 Jan 2013

Klotho protein plays important role in the health of myelin

Researchers at Boston University School of Medicine (BUSM) led by Carmela Abraham, PhD, professor of biochemistry, along with Cidi Chen, PhD, and other collaborators, report that the protein Klotho plays an important role in the health of myelin, the insulating material allowing for the rapid communication between nerve cells.

31 Jan 2013

Androgens could constitute an efficient treatment against multiple sclerosis

Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study by researchers from the Laboratoire d'Imagerie et de Neurosciences Cognitives, in collaboration in particular with the "Neuroprotection et Neurorégénération: Molécules Neuroactives de Petite Taille" unit.

30 Jan 2013

Consuming carotenoid-rich foods may help prevent or delay onset of amyotrophic lateral sclerosis

New research suggests that increased consumption of foods containing colorful carotenoids, particularly beta-carotene and lutein, may prevent or delay the onset of amyotrophic lateral sclerosis (ALS).

29 Jan 2013

Quantitative MRIs evade multiple sclerosis clinicoradiologic paradox

Quantitative magnetic resonance imaging can detect microstructural changes in the spinal cords of patients with multiple sclerosis that correlate with observed differences in clinical disability, according to a cross-sectional study in Neurology.

28 Jan 2013

Positive top-line results from Biogen Idec’s peginterferon beta-1a Phase 3 trial on RRMS

Today Biogen Idec released the primary efficacy analysis and safety data from its Phase 3 pivotal clinical trial, ADVANCE.

28 Jan 2013

FDA accepts Genzyme’s LEMTRADA sBLA for review

Genzyme, a Sanofi Company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's supplemental Biologics License Application (sBLA) file seeking approval of LEMTRADA (alemtuzumab) for the treatment of relapsing multiple sclerosis (RMS).

28 Jan 2013

Everolimus treatment option for tuberous sclerosis patients

Researchers have shown that the immunosuppressant everolimus provides a potential new treatment option for patients with tuberous sclerosis and associated angiomyolipomas.

25 Jan 2013

Effective therapy needed for chronic fatigue syndrome patients

Ampligen, the first drug ever seeking approval to treat chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME), recently hit another roadblock with the U.S. Food and Drug Administration (FDA).

25 Jan 2013

Researchers to develop new diagnostic tools and treatments for people with rare diseases

A multi-million Euro initiative is bringing together researchers from across the world to develop new diagnostic tools and new treatments for people with rare diseases and to connect research data in this area on a global scale.

25 Jan 2013

DFG now extends funding for research on immunological therapy at Charité

The DFG (Deutsche Forschungsgemeinschaft) has now extended the funding of a research association which is located at the Charité - Universitätsmedizin Berlin. The Collaborative Research Centre (SFB) will receive funding in excess of ten million Euros over the next four years.

23 Jan 2013

Neuronal reprogramming may help treat neurodegenerative diseases

A new finding by Harvard stem cell biologists turns one of the basics of neurobiology on its head - demonstrating that it is possible to turn one type of already differentiated neuron into another within the brain.

22 Jan 2013

Scientists identify new mechanism that turns CD4 helper T lymphocytes into killer cells

A research team led by the La Jolla Institute for Allergy & Immunology has discovered the mechanism that enables CD4 helper T cells to assume the more aggressive role of killer T cells in mounting an immune attack against viruses, cancerous tumors and other damaged or infected cells.

21 Jan 2013

NSU to host conference on neuro immune conditions

Nova Southeastern University (NSU) will be hosting a conference on Saturday, Jan. 26 about the upcoming opening of the NSU College of Osteopathic Medicine's Institute for Neuro Immune Medicine.

19 Jan 2013

Sclerosis News and Research

Patients with MS more likely to develop MI and stroke, regardless of migration background

NSU-COM to hold grand opening for America's first Institute for Neuro Immune Medicine

USPTO issues patent to KAHR-101 for treatment of cancers, arthritis and MS

Adequate vitamin D levels during young adulthood may reduce risk of type 1 diabetes

Eating brightly colored fruit and veg may help prevent ALS

Three Robert Wood Johnson members win Edward J. Ill Excellence in Medicine Awards

Supplementation with omega-3 fatty acids promotes effective immune system response

Klotho protein plays important role in the health of myelin

Androgens could constitute an efficient treatment against multiple sclerosis

Consuming carotenoid-rich foods may help prevent or delay onset of amyotrophic lateral sclerosis

Quantitative MRIs evade multiple sclerosis clinicoradiologic paradox

Positive top-line results from Biogen Idec’s peginterferon beta-1a Phase 3 trial on RRMS

FDA accepts Genzyme’s LEMTRADA sBLA for review

Everolimus treatment option for tuberous sclerosis patients

Effective therapy needed for chronic fatigue syndrome patients

Researchers to develop new diagnostic tools and treatments for people with rare diseases

DFG now extends funding for research on immunological therapy at Charité

Neuronal reprogramming may help treat neurodegenerative diseases

Scientists identify new mechanism that turns CD4 helper T lymphocytes into killer cells

NSU to host conference on neuro immune conditions

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News